Hong Kong · Delayed Price · Currency is HKD Qyuns Therapeutics Statistics
Total Valuation
HKG:2509 has a market cap or net worth of HKD 3.67 billion. The enterprise value is 3.23 billion.
| Market Cap | 3.67B |
| Enterprise Value | 3.23B |
Important Dates
The last earnings date was Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2509 has 223.37 million shares outstanding. The number of shares has increased by 1.28% in one year.
| Current Share Class | 223.37M |
| Shares Outstanding | 223.37M |
| Shares Change (YoY) | +1.28% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 4.48% |
| Owned by Institutions (%) | 14.47% |
| Float | 105.58M |
Valuation Ratios
The trailing PE ratio is 5.86 and the forward PE ratio is 16.39.
| PE Ratio | 5.86 |
| Forward PE | 16.39 |
| PS Ratio | 3.10 |
| PB Ratio | 3.78 |
| P/TBV Ratio | 3.70 |
| P/FCF Ratio | 6.20 |
| P/OCF Ratio | 6.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.78, with an EV/FCF ratio of 5.47.
| EV / Earnings | 5.13 |
| EV / Sales | 2.73 |
| EV / EBITDA | 4.78 |
| EV / EBIT | 5.05 |
| EV / FCF | 5.47 |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.82.
| Current Ratio | 2.29 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | 1.17 |
| Debt / FCF | 1.34 |
| Interest Coverage | 30.49 |
Financial Efficiency
Return on equity (ROE) is 101.58% and return on invested capital (ROIC) is 29.16%.
| Return on Equity (ROE) | 101.58% |
| Return on Assets (ROA) | 22.80% |
| Return on Invested Capital (ROIC) | 29.16% |
| Return on Capital Employed (ROCE) | 41.75% |
| Weighted Average Cost of Capital (WACC) | 10.61% |
| Revenue Per Employee | 3.35M |
| Profits Per Employee | 1.79M |
| Employee Count | 353 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.41 |
Taxes
| Income Tax | -84,276 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.79% in the last 52 weeks. The beta is 1.49, so HKG:2509's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -41.79% |
| 50-Day Moving Average | 16.50 |
| 200-Day Moving Average | 18.12 |
| Relative Strength Index (RSI) | 44.09 |
| Average Volume (20 Days) | 79,360 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2509 had revenue of HKD 1.18 billion and earned 630.46 million in profits. Earnings per share was 2.80.
| Revenue | 1.18B |
| Gross Profit | 1.05B |
| Operating Income | 640.76M |
| Pretax Income | 619.81M |
| Net Income | 630.46M |
| EBITDA | 674.77M |
| EBIT | 640.76M |
| Earnings Per Share (EPS) | 2.80 |
Balance Sheet
The company has 1.20 billion in cash and 792.55 million in debt, with a net cash position of 410.84 million or 1.84 per share.
| Cash & Cash Equivalents | 1.20B |
| Total Debt | 792.55M |
| Net Cash | 410.84M |
| Net Cash Per Share | 1.84 |
| Equity (Book Value) | 971.31M |
| Book Value Per Share | 4.45 |
| Working Capital | 868.09M |
Cash Flow
In the last 12 months, operating cash flow was 600.21 million and capital expenditures -8.63 million, giving a free cash flow of 591.58 million.
| Operating Cash Flow | 600.21M |
| Capital Expenditures | -8.63M |
| Depreciation & Amortization | 34.45M |
| Net Borrowing | 60.09M |
| Free Cash Flow | 591.58M |
| FCF Per Share | 2.65 |
Margins
Gross margin is 88.64%, with operating and profit margins of 54.17% and 53.30%.
| Gross Margin | 88.64% |
| Operating Margin | 54.17% |
| Pretax Margin | 52.40% |
| Profit Margin | 53.30% |
| EBITDA Margin | 57.05% |
| EBIT Margin | 54.17% |
| FCF Margin | 49.39% |
Dividends & Yields
HKG:2509 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.28% |
| Shareholder Yield | -1.28% |
| Earnings Yield | 17.19% |
| FCF Yield | 16.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |